Medicine and Dentistry
Esophageal Adenocarcinoma
100%
Patient
58%
Biological Marker
48%
Therapeutic Procedure
34%
Adenocarcinoma
34%
Prognosis
33%
Protein
28%
Epidermal Growth Factor Receptor 2
26%
Overall Survival
23%
Primary Tumor
20%
Esophageal Cancer
19%
Chlordane
14%
Prognostic Factor
14%
Lymph Node Metastasis
13%
Chemoradiotherapy
12%
Surgery
12%
Tumor Microenvironment
11%
Death
11%
Stroma
10%
B Cell
10%
Hazard Ratio
10%
Neoadjuvant Therapy
9%
Interferon
8%
B Lymphocyte
8%
Learning
8%
RNA Recognition Motif
8%
Krukenberg Tumor
8%
Secretory Component
8%
Neoadjuvant Chemotherapy
8%
Synapsin II
8%
T Lymphocyte
8%
Tissue Microarray
8%
Cancer Types
6%
Targeted Therapy
6%
Biopsy
6%
Chemotherapy
6%
Association
5%
Cells
5%
Proportional Hazards Model
5%
Immunology and Microbiology
Macrophage
26%
Density
19%
CD163
17%
B Cell
17%
CD68
17%
T Cell
17%
Immunocompetent Cell
16%
Programmed Death-Ligand 1
15%
Mismatch Repair
15%
CD8
13%
Prognostic Biomarker
8%
Lymphocyte Activation
8%
Matrix Protein
8%
Cartilage
8%
Tumor-Associated Macrophage
8%
Gamma Urogastrone
8%
Macrophage Subset
5%
Biochemistry, Genetics and Molecular Biology
Macrophage
17%
Protein
13%
Binding Protein
10%
DNA Mismatch Repair
8%
Eicosanoid Receptor
8%
Solid
8%
Intravenous Immunoglobulin
5%
Stomach
5%
Esophagus
5%
